XML 56 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Cash, Cash Equivalents, and Marketable Securities (Notes)
9 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES
CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES

The following tables categorize the fair values of cash, cash equivalents, and marketable securities measured at fair value on a recurring basis on our balance sheet (in millions):
 
 
 
September 30, 2016
 
Fair Value
 Level
 
Automotive
 
Financial Services
 
All
Other
 
Consolidated
Cash and cash equivalents
 
 
 
 
 
 
 
 
 
U.S. government
1
 
$
599

 
$

 
$

 
$
599

U.S. government agencies
2
 

 
4

 

 
4

Non-U.S. government and agencies
2
 
551

 
280

 

 
831

Corporate debt
2
 
60

 
50

 

 
110

Total marketable securities classified as cash equivalents
 
 
1,210

 
334

 

 
1,544

Cash, time deposits, and money market funds
 
 
6,445

 
5,341

 
10

 
11,796

Total cash and cash equivalents
 
 
$
7,655

 
$
5,675

 
$
10

 
$
13,340

 
 
 
 
 
 
 
 
 
 
Marketable securities
 
 
 
 
 
 
 
 
 
U.S. government
1
 
$
3,982

 
$
1,724

 
$

 
$
5,706

U.S. government agencies
2
 
3,284

 
1,354

 

 
4,638

Non-U.S. government and agencies
2
 
5,423

 
520

 

 
5,943

Corporate debt
2
 
3,709

 
540

 

 
4,249

Equities
1
 
198

 

 

 
198

Other marketable securities
2
 
49

 
42

 

 
91

Total marketable securities
 
 
$
16,645

 
$
4,180

 
$

 
$
20,825

 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2015
 
Fair Value
 Level
 
Automotive
 
Financial Services
 
All
Other
 
Consolidated
Cash and cash equivalents
 
 
 
 
 
 
 
 
 
U.S. government
1
 
$
115

 
$

 
$

 
$
115

U.S. government agencies
2
 
22

 

 

 
22

Non-U.S. government and agencies
2
 
173

 
266

 

 
439

Corporate debt
2
 
20

 

 

 
20

Total marketable securities classified as cash equivalents
 
 
330

 
266

 

 
596

Cash, time deposits, and money market funds
 
 
5,056

 
8,620

 

 
13,676

Total cash and cash equivalents
 
 
$
5,386

 
$
8,886

 
$

 
$
14,272

 
 
 
 
 
 
 
 
 
 
Marketable securities
 
 
 
 
 
 
 
 
 
U.S. government
1
 
$
1,623

 
$
298

 
$

 
$
1,921

U.S. government agencies
2
 
5,240

 
1,169

 

 
6,409

Non-U.S. government and agencies
2
 
7,451

 
832

 

 
8,283

Corporate debt
2
 
3,279

 
384

 

 
3,663

Equities
1
 
240

 

 

 
240

Other marketable securities
2
 
348

 
40

 

 
388

Total marketable securities
 
 
$
18,181

 
$
2,723

 
$

 
$
20,904



NOTE 4. CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES (Continued)

The following tables present cash equivalents and marketable securities accounted for as available-for-sale (“AFS”) securities on our balance sheet (in millions):
 
September 30, 2016
 
 
 
 
 
 
 
 
 
Fair Value of Securities with
Contractual Maturities:
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
 
Less than 1 Year
 
1-5 Years
Automotive
 
 
 
 
 
 
 
 
 
 
 
U.S. government
$
447

 
$

 
$

 
$
447

 
$

 
$
447

U.S. government agencies
100

 

 

 
100

 

 
100

Non-U.S. government and agencies
77

 

 

 
77

 

 
77

Corporate debt
337

 

 

 
337

 
247

 
90

Total
$
961

 
$

 
$

 
$
961

 
$
247

 
$
714

 
 
 
 
 
 
 
 

 
 
 
 
 
December 31, 2015
 
 
 
 
 
 
 
 
 
Fair Value of Securities with
Contractual Maturities:
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
 
Less than 1 Year
 
1-5 Years
Automotive
 
 
 
 
 
 
 
 
 
 
 
U.S. government
$

 
$

 
$

 
$

 
$

 
$

U.S. government agencies

 

 

 

 

 

Non-U.S. government and agencies
82

 

 
(12
)
 
70

 

 
70

Corporate debt

 

 

 

 

 

Total
$
82

 
$

 
$
(12
)
 
$
70

 
$

 
$
70



Sales proceeds for investments classified as AFS and sold prior to maturity were $69 million and $0 for the nine months ended September 30, 2016 and 2015, respectively. Gross realized gains from the sale of AFS securities were $1 million and $0 for the nine months ended September 30, 2016 and 2015, respectively. There were no gross realized losses from the sale of AFS securities for the nine months ended September 30, 2016 and 2015.

We determine other-than-temporary impairments on cash equivalents and marketable securities using a specific identification method. During the nine months ended September 30, 2016 and 2015, we did not recognize any other-than-temporary impairment loss.